Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XRAY
XRAY logo

XRAY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
10.645
Open
10.320
VWAP
10.45
Vol
7.72M
Mkt Cap
2.10B
Low
10.230
Amount
80.69M
EV/EBITDA(TTM)
7.35
Total Shares
200.33M
EV
4.14B
EV/OCF(TTM)
15.46
P/S(TTM)
0.57
DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
Show More

Events Timeline

(ET)
2026-05-05
16:20:00
Dentsply Sirona Reports Q1 Revenue of $880M
select
2026-05-05
16:20:00
Company Maintains FY26 Revenue Outlook of $3.5B-$3.6B
select
2026-05-04 (ET)
2026-05-04
17:10:00
Dentsply Sirona Announces New Agreement with Atlanta Dental Supply
select
2026-03-09 (ET)
2026-03-09
08:40:00
Dentsply Sirona and Siemens Healthineers Share Key Findings from Dental MRI Clinical Trial
select

News

Newsfilter
7.5
05-26Newsfilter
Dentsply Sirona Expands U.S. Distribution Network
  • Strengthened Partnership: Dentsply Sirona's partnership with Nashville Dental, Inc. will take effect on August 1, 2026, allowing NDI to distribute the full range of Dentsply Sirona's digital technology solutions across nine states, enhancing the company's market penetration in the Southeast and Mid-Atlantic regions.
  • Promotion of Digital Technologies: The collaboration with NDI will introduce Dentsply Sirona's CEREC system, Primescan intraoral scanners, and digital imaging solutions to more dental practices, addressing the growing demand for digital dentistry and driving the adoption of digitally connected workflows.
  • Localized Service Advantage: NDI, as a well-established full-service organization, provides support in equipment technology, installation, service, and practice advisory, ensuring that customers receive localized service and support when utilizing Dentsply Sirona's digital solutions, thereby enhancing customer satisfaction.
  • Market Strategy Optimization: This agreement underscores Dentsply Sirona's strategic focus in the U.S. market, aiming to enhance market accessibility through a balanced mix of direct and indirect channels, promoting the adoption of digital dental solutions and supporting the company's long-term growth objectives.
Yahoo Finance
5.0
05-10Yahoo Finance
DENTSPLY SIRONA Launches AI Dental Imaging Tool Smart View, Detect
  • FDA Approval of New Product: DENTSPLY SIRONA launched Smart View, Detect, the first FDA-cleared AI-powered CBCT diagnostic aid, marking a significant innovation in digital dentistry, despite a 28.5% decline in its stock price over the past year.
  • Sales and Income Challenges: First-quarter 2026 sales were $880 million, roughly flat year-over-year, but the company swung from a net income of $20 million to a net loss of $10 million, indicating fragile profitability while maintaining full-year sales guidance of $3.5 billion to $3.6 billion.
  • Expanded Distribution Agreement: DENTSPLY SIRONA expanded its U.S. distribution agreement with Atlanta Dental Supply, aiming to enhance market access for its digital dentistry solutions, although facing pressure from larger competitors.
  • Advancement of Digital Strategy: The launch of Smart View, Detect integrated with the DS Core platform aims to drive growth in digital platforms and software subscription revenues, yet the conversion from product launches to sustained revenue growth remains a challenge.
NASDAQ.COM
2.0
05-06NASDAQ.COM
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
seekingalpha
9.5
05-06seekingalpha
DENTSPLY SIRONA Q1 2026 Earnings Call Insights
  • Revenue and Earnings Performance: DENTSPLY SIRONA reported Q1 revenue of $880 million and adjusted EPS of $0.27, with operating cash flow at $40 million, while the net debt-to-EBITDA ratio stood at 3.3x, indicating financial pressure.
  • Restructuring and Innovation Plans: The company is implementing U.S. commercial restructuring, expanded clinical education, and sales training to redirect funds for future commercial and innovation growth, although the benefits of these actions are expected to materialize more in 2027 and beyond.
  • 2026 Outlook Unchanged: Management maintained its 2026 guidance for net sales of $3.5 billion to $3.6 billion and adjusted EPS in the range of $1.40 to $1.50, reflecting cautious optimism about future performance.
  • Market Pressures and Risks: Management highlighted tariffs, sales mix, and dealer destocking as factors pressuring gross margins, yet the company plans to evaluate the timing of share repurchases in the second half to enhance capital allocation flexibility.
seekingalpha
9.5
05-05seekingalpha
Dentsply Sirona Q1 Earnings Beat Expectations
  • Earnings Performance: Dentsply Sirona reported a Q1 non-GAAP EPS of $0.27, aligning with expectations, indicating stability in the company's profitability.
  • Revenue Growth: The company achieved Q1 revenue of $880 million, a slight increase of 0.1% year-over-year, beating market expectations by $39.92 million, demonstrating its strong competitive position.
  • Future Outlook: Dentsply Sirona maintains its 2026 net sales outlook in the range of $3.5 billion to $3.6 billion, slightly below the $3.58 billion consensus, reflecting confidence in future growth.
  • Stock Price Reaction: Following the earnings release, Dentsply Sirona's shares rose by 2%, indicating positive investor sentiment regarding the company's performance and outlook.
Newsfilter
7.5
05-04Newsfilter
Dentsply Sirona Enhances Distribution Agreement with Atlanta Dental Supply
  • Enhanced Distribution Agreement: Dentsply Sirona has signed an enhanced distribution agreement with Atlanta Dental Supply, effective August 1, allowing the latter to offer Dentsply Sirona's digital dentistry technology solutions, thereby expanding its influence in the U.S. market.
  • Strengthened Market Strategy: By partnering with Atlanta Dental Supply, Dentsply Sirona can leverage deep customer relationships in the Southeast to improve market penetration of digital dental products, thus enhancing customer acquisition capabilities.
  • Technology Product Expansion: The new agreement enables Atlanta Dental Supply to offer key digital dentistry technologies, including the CEREC system, intraoral scanning, and digital imaging solutions, addressing the market's demand for efficient dental solutions.
  • Customer-Centric Execution: Mark Bezjak, Group Vice President, emphasizes that expanding access to digital dentistry technologies is a core element of their commercial strategy, highlighting the importance of trusted distribution partners for customer-centric and localized execution.
Wall Street analysts forecast XRAY stock price to rise
16 Analyst Rating
Wall Street analysts forecast XRAY stock price to rise
2 Buy
13 Hold
1 Sell
Hold
Current: 0.000
sliders
Low
12.00
Averages
13.04
High
17.00
Current: 0.000
sliders
Low
12.00
Averages
13.04
High
17.00
UBS
Buy
to
Buy
downgrade
$18 -> $17
AI Analysis
2026-05-07
Reason
UBS
Price Target
$18 -> $17
AI Analysis
2026-05-07
downgrade
Buy
to
Buy
Reason
UBS lowered the firm's price target on Dentsply Sirona to $17 from $18 and keeps a Buy rating on the shares.
Mizuho
Neutral
downgrade
$16 -> $14
2026-05-06
Reason
Mizuho
Price Target
$16 -> $14
2026-05-06
downgrade
Neutral
Reason
Mizuho lowered the firm's price target on Dentsply Sirona to $14 from $16 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for XRAY
Unlock Now

Valuation Metrics

The current forward P/E ratio for DENTSPLY SIRONA Inc (XRAY.O) is 7.09, compared to its 5-year average forward P/E of 14.80. For a more detailed relative valuation and DCF analysis to assess DENTSPLY SIRONA Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
14.80
Current PE
7.09
Overvalued PE
20.29
Undervalued PE
9.31

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
5.59
Current EV/EBITDA
8.67
Overvalued EV/EBITDA
32.08
Undervalued EV/EBITDA
-20.89

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.68
Current PS
0.55
Overvalued PS
2.46
Undervalued PS
0.91

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

todays top stocks to gain?
Intellectia · 57 candidates
Market Cap: >= 300.00MRegion: USPrice: $3.00 - $500.00Volume: >= 1,000,000Price Change Pct: >= $5.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
AAOI logo
AAOI
Applied Optoelectronics Inc
6.33B
ARLO logo
ARLO
Arlo Technologies Inc
1.68B
PRAA logo
PRAA
PRA Group Inc
605.63M
FIGS logo
FIGS
Figs Inc
2.57B
DELL logo
DELL
Dell Technologies Inc
98.13B
XRAY logo
XRAY
DENTSPLY SIRONA Inc
2.93B

Whales Holding XRAY

P
Paradigm Capital Management, Inc.
Holding
XRAY
+21.80%
3M Return
A
Armistice Capital LLC
Holding
XRAY
+6.75%
3M Return
I
Invenomic Capital Management LP
Holding
XRAY
+3.38%
3M Return
A
Ariel Investments, LLC
Holding
XRAY
-3.53%
3M Return
C
Cooke & Bieler, L.P.
Holding
XRAY
-4.52%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is DENTSPLY SIRONA Inc (XRAY) stock price today?

The current price of XRAY is 10.47 USD — it has increased 1.75

What is DENTSPLY SIRONA Inc (XRAY)'s business?

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.

What is the price predicton of XRAY Stock?

Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is13.04 USD with a low forecast of 12.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is DENTSPLY SIRONA Inc (XRAY)'s revenue for the last quarter?

DENTSPLY SIRONA Inc revenue for the last quarter amounts to 880.00M USD, increased 0.11

What is DENTSPLY SIRONA Inc (XRAY)'s earnings per share (EPS) for the last quarter?

DENTSPLY SIRONA Inc. EPS for the last quarter amounts to -0.05 USD, decreased -150.00

How many employees does DENTSPLY SIRONA Inc (XRAY). have?

DENTSPLY SIRONA Inc (XRAY) has 14000 emplpoyees as of June 01 2026.

What is DENTSPLY SIRONA Inc (XRAY) market cap?

Today XRAY has the market capitalization of 2.10B USD.